MedGenome Raises $55 Mn In Fresh Funding To Expand In Tier 2-3 Markets

MedGenome Raises $55 Mn In Fresh Funding To Expand In Tier 2-3 Markets

SUMMARY

The investment has been led by LeapFrog Investments

Existing investors Sequoia Capital and Sofina also invested in the round

The fresh funding will help the company's drug discovery programmes

Bengaluru-based healthtech startup MedGenome has raised $55 Mn in a fresh funding round. The investment has been reportedly led by LeapFrog Investments with the participation of existing investors Sequoia Capital and Sofina.

The funding will be used towards expanding its clinical genomic testing in Tier 2 and 3 cities and smaller towns. It will also invest in accelerating its drug discovery programs. Prior to this round, the company has raised $55 Mn in funding,

Founded by Sam Santhosh in 2013, MedGenome is a genetic diagnostic testing company. The company claims to have built the largest database of South Asian genome variants in genetic diagnostics in India and research partnerships.

It claims to have completed over 200K genomic tests to date and obtains samples from more than 550 hospitals and 6,000 clinicians across India.

“Genomics and personalised medicine are the future of healthcare, but emerging markets remain significantly under-penetrated. As the largest player in India in applied genomics, we are well-positioned to fill this gap,” said Sam Santhosh, founder and chief executive of MedGenome.

Felix Olale, global co-lead for healthcare investment at LeapFrog said that the funding will help the company the development of new drug discovery platforms that will have an enormous impact on cancer and cardiovascular disease.

MedGenome’s diagnostics tests include many breakthroughs for genetic diagnostics including the first proprietary liquid biopsy (OncoTrack) for monitoring cancer treatment, a non-invasive prenatal screening test (NIPT) for pregnant women, carrier screening for couples planning for children, and whole-exome sequencing for cost-effective identification of rare mutations.

Globally, the market is expected to more than double, to touch $28.5 Bn by 2026, up from $13 Bn in 2019.

One of the competitors of MedGenome is Hyderabad-based MapMyGenome. The company is behind the personal genomics and predictive tests brand Genomepatri. It uses state-of-the-art technology to decode and understand an individual’s DNA and provides actionable steps for individuals and their physicians towards a healthier life. It offers a plethora of mapping tests for genomics, cardiology, oncology, gynaecology and neurology.

According to DataLabs by Inc42, the healthtech sector recorded total funding of $586.93 Mn in 2019, an increase of over 10% in the amount of funding from the previous year.

According to Datalabs by Inc42, there are over 4800 healthtech startups in India till 2018. These startups are leveraging new-age technologies such as artificial intelligence (AI) and Internet of Things (IoT) to develop solutions which are effective in these situations.

You have reached your limit of free stories
Become An Inc42 Plus Member

Become a Startup Insider in 2024 with Inc42 Plus. Join our exclusive community of 10,000+ founders, investors & operators and stay ahead in India’s startup & business economy.

2 YEAR PLAN
₹19999
₹7999
₹333/Month
UNLOCK 60% OFF
Cancel Anytime
1 YEAR PLAN
₹9999
₹4999
₹416/Month
UNLOCK 50% OFF
Cancel Anytime
Already A Member?
Discover Startups & Business Models

Unleash your potential by exploring unlimited articles, trackers, and playbooks. Identify the hottest startup deals, supercharge your innovation projects, and stay updated with expert curation.

MedGenome Raises $55 Mn In Fresh Funding To Expand In Tier 2-3 Markets-Inc42 Media
How-To’s on Starting & Scaling Up

Empower yourself with comprehensive playbooks, expert analysis, and invaluable insights. Learn to validate ideas, acquire customers, secure funding, and navigate the journey to startup success.

MedGenome Raises $55 Mn In Fresh Funding To Expand In Tier 2-3 Markets-Inc42 Media
Identify Trends & New Markets

Access 75+ in-depth reports on frontier industries. Gain exclusive market intelligence, understand market landscapes, and decode emerging trends to make informed decisions.

MedGenome Raises $55 Mn In Fresh Funding To Expand In Tier 2-3 Markets-Inc42 Media
Track & Decode the Investment Landscape

Stay ahead with startup and funding trackers. Analyse investment strategies, profile successful investors, and keep track of upcoming funds, accelerators, and more.

MedGenome Raises $55 Mn In Fresh Funding To Expand In Tier 2-3 Markets-Inc42 Media
MedGenome Raises $55 Mn In Fresh Funding To Expand In Tier 2-3 Markets-Inc42 Media
You’re in Good company